Business Daily from THE HINDU group of publications
Thursday, Jun 12, 2008
ePaper | Mobile/PDA Version | Audio


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Home Page - Stocks
Markets - Recommendation
Get Latest BSE Quote
Crompton Greaves (Rs 251.55): Buy


We recommend a buy in Crompton Greaves from a short-term perspective. The stock was on a long-term downtrend from its November 2007 high of Rs 454, till it found support at around Rs 220 during May 2008. This (Rs 220) is a significant support level for the stock. Subsequently, the stock breached the long-term down trend-line and commenced its up move.

We believe that the long-term downtrend has come to an end. On June 11, the stock gained momentum by jumping up 5 per cent with above-average volume, penetrating the 50-day moving average. The daily Relative Strength Index is heading towards the bullish zone and the weekly RSI has recovered from the bearish zone. After displaying positive divergence, the moving average convergence and divergence is on the brink of entering the positive territory.

We are bullish on the stock in the short-term. We expect the stock to trend upwards until it hits our price target of Rs 280 in the approaching trading sessions. Traders with short-term perspective can buy the stock, while maintaining the stop-loss at Rs 238 level.

Yoganand D.

Related Stories:
Crompton buys French firm
Crompton Greaves ties up with Dutch company
Crompton Greaves Q4 net up 47%

More Stories on : Stocks | Recommendation | Electrical Goods

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Hiring

Stories in this Section
Monsoon hits Nagpur even as systems weaken


Farmers likely to feel the pinch of di-ammonium phosphate shortage
High global prices spoil fertiliser party
Panel to help combat aviation fuel price rise
Daiichi Sankyo to buy 51% in Ranbaxy at Rs 737/share
‘This sale is for strategic growth’
Ranbaxy stake sale — When predator turned prey
Ranbaxy to serve Japanese generic ambitions
‘We want to be number one player in Japan’
Premium for Ranbaxy buy among the highest
Essar hikes offer for Esmark to $19 a share
Sponge iron unit sale positive for Grasim
PSL: Buoyant order flows spell strong revenue visibility
Crompton Greaves (Rs 251.55): Buy
Ranbaxy: ‘Bought on rumour and sold on news’
Day Trading Guide
Banks begin to rejig investment portfolios
Repo rate hike: Analysts expect market to open weak today
US Bill seeks to ease green card restrictions
RBI hikes repo rate to 8%
Valuing art: The role of provenance and auction
‘IPL franchisees may have better margins than Arsenal, Man U’


Brandline



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line